Features | Partner Sites | Information | LinkXpress
Sign In

Drug Discovery

Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission has approved a new therapeutic option for the most difficult to treat form of ovarian cancer.  More...
18 Aug 2014

Naturally Derived Plant Compounds Protect Skin during Cancer Radiotherapy

Plant-derived natural compounds may provide protection to the skin from the damaging effects of gamma radiation during cancer radiotherapy, according to new research.  More...
06 Aug 2014

New Drug Shown to Be Effective Against Malaria Using Synchrotron Light

 Spanish and Scottish investigators have shown that a new drug is an effective option in the battle against malaria.  More...
04 Aug 2014
Image: XPro1595 is a clinical stage inhibitor of soluble TNFalpha (sTNF) for the treatment of neurodegenerative diseases including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). As a result of its unique mechanism of action, XPro1595 is positioned as not only for symptomatic treatment for these devastating diseases but as a disease modifying therapy as well (Photo  courtesy of FPRT Bio).

Experimental Drug Slows Progress of Parkinson's Disease in Rat Model

In a series of experiments designed to set the stage for future human clinical trials, an experimental anti-inflammatory drug was shown to prevent loss of dopamine-producing neurons and to reduce motor deficits in a rat model of Parkinson’s disease.  More...
04 Aug 2014

Pill Appearance Key to Patient Compliance

Heart attack patients are 30% more likely to discontinue generic cardiovascular medications if their pills change in color or shape, according to a new study.  More...
31 Jul 2014

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research.   More...
30 Jul 2014
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome. More...
22 Jul 2014

The Drug Discovery channel in BioResearch informs about the biotechnology of drug discovery and design from traditional to translational pharma within the five-year horizon.
Copyright © 2000-2015 Globetech Media. All rights reserved.